Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
O.K. Corral: FDA sets stage to appeal California Stem Cell Treatment Center decision

O.K. Corral: FDA sets stage to appeal California Stem Cell Treatment Center decision

by admin | Jan 22, 2023 | News & Opinions

Michael Druckman, Meredith Manning, and  Ashley Grey – Hogan Lovells Last year, a federal court in California ruled against the U.S. Food and Drug Administration (FDA) in a matter where the government alleged that a stem cell clinic’s products should be...
Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

by admin | Jan 20, 2023 | News & Opinions

by William A. Haseltine  – Forbes Here we describe early clinical trial results on combination CRISPR and CAR T therapy, a sequel to an earlier, introductory piece. Other alternative CAR T designs include mRNA vectors to create temporary CAR T cells and the use...
Auto Draft

The future of replacement organs is (quite possibly) here: Robust human intestinal organoids created in a lab

by admin | Jan 19, 2023 | News & Opinions

by Tokyo Medical and Dental University – Phys.org Growing miniature organ-like tissues in the lab is already within our reach. Now, researchers from Japan have developed a new approach that enables intestinal mini-organs to be grown more easily and efficiently...
MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial

MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial

by admin | Jan 18, 2023 | News & Opinions

A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment. By University of Sheffield The study launched by the University of Sheffield and Sheffield Teaching Hospitals...
Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

by admin | Jan 17, 2023 | News & Opinions

CIRM grant will fund novel gene therapy aiming for one-time, lifelong treatment of Friedreich’s ataxia, a progressive neuromuscular disorder; second CIRM grant will advance efforts to leverage UC San Diego research on another rare disease By Scott LaFee – UC San...
Page 145 of 167« First«144145146»Last »

Recent Posts

  • UC Irvine receives $12 million to test novel stem cell therapy for Huntington’s disease
  • Novel surgical approach for retinal gene therapy shows promise
  • The Best Biomarkers For Longevity, According To Experts
  • Regeneron’s experimental therapy combo effective in untreated cancer patients
  • The quest to slow aging leads scientists into the powerhouse of cells
Tweets about @WSCSummit